ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 485,80
-0,05%
Dow Jones
42 528,36
-0,42%
DAX
20 340,23
-0,05%
Brent Oil
77,375
0,41%
Bitcoin
95 775,38
-1,16%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Praecis Pharmaceuticals (MM) (PRCS)

  7. Praecis Pharmaceuticals (MM) (PRCS) Actualités

PRCS

Praecis (PRCS)

Praecis Pharmaceuticals (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PRCS
DateHeureSourceTitreSymboleSociété
16/02/200714h30PR Newswire (US)GlaxoSmithKline Successfully Completes Tender Offer for Shares of PRAECIS PHARMACEUTICALSNASDAQ:PRCSPraecis Pharmaceuticals (MM)
15/02/200715h00PR Newswire (US)GlaxoSmithKline Extends Subsequent Offering Period By One DayNASDAQ:PRCSPraecis Pharmaceuticals (MM)
07/02/200715h11PR Newswire (US)GlaxoSmithKline Accepts Shares in Tender Offer for Shares of PRAECIS PHARMACEUTICALS and Commences Subsequent Offering PeriodNASDAQ:PRCSPraecis Pharmaceuticals (MM)
09/01/200715h03PR Newswire (US)GlaxoSmithKline Commences Tender Offer to Acquire PRAECIS PHARMACEUTICALSNASDAQ:PRCSPraecis Pharmaceuticals (MM)
09/11/200613h15Business WirePRAECIS PHARMACEUTICALS INCORPORATED Reports Third Quarter 2006 Financial ResultsNASDAQ:PRCSPraecis Pharmaceuticals (MM)
08/11/200613h00Business WirePRAECIS PHARMACEUTICALS INCORPORATED Presents Interim Clinical Data on PPI-2458 at the 18th EORTC-NCI-AACR SymposiumNASDAQ:PRCSPraecis Pharmaceuticals (MM)
01/11/200620h02Business WirePRAECIS PHARMACEUTICALS INCORPORATED To Announce Third Quarter Financial Results on Thursday, November 9, 2006NASDAQ:PRCSPraecis Pharmaceuticals (MM)
24/10/200613h00Business WirePRAECIS PHARMACEUTICALS INCORPORATED Receives the Cerep Award for Research Related to Its Investigational Drug Candidate, PPI-24NASDAQ:PRCSPraecis Pharmaceuticals (MM)
18/10/200613h00Business WirePRAECIS PHARMACEUTICALS INCORPORATED Presents Preclinical Data on PPI-2458NASDAQ:PRCSPraecis Pharmaceuticals (MM)
04/08/200613h00Business WirePRAECIS PHARMACEUTICALS INCORPORATED Reports Second Quarter 2006 Financial ResultsNASDAQ:PRCSPraecis Pharmaceuticals (MM)
01/08/200622h30Business WirePRAECIS PHARMACEUTICALS INCORPORATED to Announce Second Quarter Financial Results on Friday, August 4, 2006NASDAQ:PRCSPraecis Pharmaceuticals (MM)
20/06/200613h00Business WirePRAECIS PHARMACEUTICALS INCORPORATED Announces Cessation of Plenaxis(R) Disposition Efforts; Plans to Explore Financing AlternaNASDAQ:PRCSPraecis Pharmaceuticals (MM)
05/05/200613h00Business WirePRAECIS PHARMACEUTICALS INCORPORATED Reports First Quarter 2006 Financial ResultsNASDAQ:PRCSPraecis Pharmaceuticals (MM)
28/04/200613h30Business WirePRAECIS PHARMACEUTICALS INCORPORATED To Announce First Quarter Financial Results on Friday, May 5, 2006NASDAQ:PRCSPraecis Pharmaceuticals (MM)
20/04/200614h00Business WirePRAECIS PHARMACEUTICALS INCORPORATED Appoints Prem Das as Senior Vice President, Technology PartnershipsNASDAQ:PRCSPraecis Pharmaceuticals (MM)
10/04/200613h30Business WirePRAECIS PHARMACEUTICALS INCORPORATED Announces Pilot Study and Option Agreement with GlaxoSmithKline to Utilize DirectSelect(TMNASDAQ:PRCSPraecis Pharmaceuticals (MM)
21/03/200613h30Business WirePRAECIS PHARMACEUTICALS INCORPORATED Announces Technology Transfer and Option Agreement with Gilead Sciences, Inc. to Utilize DNASDAQ:PRCSPraecis Pharmaceuticals (MM)
15/03/200614h30Business WirePRAECIS PHARMACEUTICALS INCORPORATED Presents Update on its DirectSelect(TM) TechnologyNASDAQ:PRCSPraecis Pharmaceuticals (MM)
09/03/200620h00Business WirePRAECIS PHARMACEUTICALS INCORPORATED Presents Preclinical Data on PPI-2458 in Rheumatoid ArthritisNASDAQ:PRCSPraecis Pharmaceuticals (MM)
03/02/200613h00Business WirePRAECIS PHARMACEUTICALS INCORPORATED Reports Fourth Quarter and Year End 2005 Financial ResultsNASDAQ:PRCSPraecis Pharmaceuticals (MM)
30/01/200620h40Business WirePRAECIS PHARMACEUTICALS INCORPORATED To Announce Fourth Quarter and Year End 2005 Financial Results on Friday, February 3, 2006NASDAQ:PRCSPraecis Pharmaceuticals (MM)
08/11/200500h15Business WirePRAECIS PHARMACEUTICALS INCORPORATED To Present at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference on November 9,NASDAQ:PRCSPraecis Pharmaceuticals (MM)
04/11/200513h00Business WirePRAECIS PHARMACEUTICALS INCORPORATED Reports Third Quarter 2005 Financial ResultsNASDAQ:PRCSPraecis Pharmaceuticals (MM)
01/11/200513h00Business WirePRAECIS PHARMACEUTICALS INCORPORATED To Announce Third Quarter 2005 Financial Results on Friday, November 4, 2005NASDAQ:PRCSPraecis Pharmaceuticals (MM)
27/10/200522h17Business WirePRAECIS PHARMACEUTICALS INCORPORATED Stockholders Authorize Reverse Stock Split; Board Sets 1-for-5 Split RatioNASDAQ:PRCSPraecis Pharmaceuticals (MM)
19/10/200513h00Business WirePRAECIS PHARMACEUTICALS INCORPORATED Completes Sale of Facility for $51.25 MillionNASDAQ:PRCSPraecis Pharmaceuticals (MM)
11/10/200515h12Business WirePRAECIS PHARMACEUTICALS INCORPORATED Announces Agreement for Sale of FacilityNASDAQ:PRCSPraecis Pharmaceuticals (MM)
29/09/200502h00Business WirePRAECIS PHARMACEUTICALS INCORPORATED Announces German Regulatory Approval for Plenaxis(R); Schering AG Collaboration TerminatedNASDAQ:PRCSPraecis Pharmaceuticals (MM)
05/08/200513h00Business WirePRAECIS PHARMACEUTICALS INCORPORATED Reports Second Quarter 2005 Financial ResultsNASDAQ:PRCSPraecis Pharmaceuticals (MM)
06/05/200513h00Business WirePRAECIS PHARMACEUTICALS INCORPORATED Reports First Quarter 2005 Financial ResultsNASDAQ:PRCSPraecis Pharmaceuticals (MM)
 Showing the most relevant articles for your search:NASDAQ:PRCS

Dernières Valeurs Consultées

EU
VK
Vallourec
COIN
SOLUSD
Solana
EU
PX1
CAC 40
EU
GLE
Societe Generale
COIN
ADAUSD
Cardano
COIN
DOGEUSD
Dogecoin
NYSE
KO
Coca Cola
NYSE
MRK
Merck
EU
LR
Legrand
EU
PX4
SBF 120
EU
ML
Michelin
NYSE
NKE
Nike
SPI
SP500
S&P 500
EU
CS
Axa
COIN
ETHUSD
Ethereum
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés